Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kaigen Of Japan Plans 10 Percent Increase In Sales Staff

This article was originally published in PharmAsia News

Executive Summary

Japan's Kaigen plans a 10 percent annual increase in its sales staff to cover more institutions for two of its primary medical products. The firm said an X-ray barium contrast agent and its Alloid G treatment for peptic ulcer and reflex account for a large percentage of its sales. Alloid G alone accounts for about 30 percent, Kaigen said, and it hopes to double those sales within the next three years. The firm said part of its failure to cover all institutions in the country was its new business selling sterilizing devices and other medical equipment. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts